Learn to Customize Your Own Options Trading Strategy

From RJO Futures | Ad

This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.

Download your FREE Options Strategy Guide Today!

URGN Insider Trading (UroGen Pharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $224,625.00

Insider Selling (Last 12 Months): $103,816.54

UroGen Pharma Insider Trading History Chart

UroGen Pharma Share Price & Price History

^$15.57

▲ +0.34 (2.23%)

As of 07/28/2021 04:24 PM ET

Days: 30 | 90 | 365

Don't Miss The Burgeoning Lithium Megatrend

From Investing Trends | Ad

By 2025... manufacturers will need 1.1 million tons of lithium. Here's how investors could take advantage of this lithium explosion.

See The Full Report On The Lithium Explosion Now

UroGen Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/26/2021	Mark Schoenberg	Insider	Sell	103	$15.30	$1,575.90
5/17/2021	Molly Henderson	CFO	Buy	2,500	$15.85	$39,625.00	2,500
4/26/2021	Mark Schoenberg	Insider	Sell	89	$19.63	$1,747.07	20,964
1/31/2021	Mark Schoenberg	Insider	Sell	1,076	$22.07	$23,747.32	21,831
1/26/2021	Mark Schoenberg	Insider	Sell	100	$22.12	$2,212.00	19,931
12/14/2020	Elizabeth A Barrett	CEO	Buy	10,000	$18.50	$185,000.00	229,117
12/4/2020	Mark Schoenberg	Insider	Sell	662	$19.85	$13,140.70	20,385
10/26/2020	Mark Schoenberg	Insider	Sell	101	$20.95	$2,115.95	19,444
10/15/2020	Peter P Pfreundschuh	CFO	Sell	2,400	$21.77	$52,248.00	12,805
9/4/2020	Mark Schoenberg	Insider	Sell	348	$20.20	$7,029.60	19,584
7/27/2020	Mark Schoenberg	Insider	Sell	70	$23.51	$1,645.70	18,613
7/27/2020	Peter P Pfreundschuh	CFO	Sell	141	$23.51	$3,314.91	7,496
6/4/2020	Mark Schoenberg	Insider	Sell	349	$27.51	$9,600.99	18,753
4/27/2020	Mark Schoenberg	Insider	Sell	70	$24.35	$1,704.50	17,781
4/27/2020	Peter P Pfreundschuh	CFO	Sell	141	$24.35	$3,433.35	6,537
4/27/2020	Stephen Mullennix	COO	Sell	145	$24.35	$3,530.75	10,229
2/14/2020	Stephen Mullennix	COO	Sell	612	$28.04	$17,160.48	10,424
1/27/2020	Mark Schoenberg	Insider	Sell	322	$29.15	$9,386.30	9,499
1/27/2020	Peter P Pfreundschuh	CFO	Sell	667	$29.28	$19,529.76	5,105
1/27/2020	Stephen Mullennix	COO	Sell	684	$29.26	$20,013.84	9,349
11/20/2019	Elizabeth A Barrett	CEO	Buy	7,470	$28.00	$209,160.00	9,018
11/20/2019	Peter P Pfreundschuh	CFO	Sell	354	$28.41	$10,057.14	3,793
11/19/2019	Mark Schoenberg	Insider	Buy	1,960	$28.17	$55,213.20
11/15/2019	Elizabeth A Barrett	CEO	Buy	1,548	$26.00	$40,248.00	1,548
11/14/2019	Stephen Mullennix	COO	Sell	608	$26.00	$15,808.00	8,291
8/20/2019	Peter P Pfreundschuh	CFO	Sell	1,416	$33.07	$46,827.12
8/15/2019	Stephen Mullennix	COO	Sell	608	$31.65	$19,243.20
5/14/2019	Stephen Mullennix	COO	Sell	608	$37.98	$23,091.84
3/21/2019	Mark Schoenberg	Insider	Buy	272	$37.01	$10,066.72
3/6/2019	Mark Schoenberg	Insider	Sell	1,991	$37.30	$74,264.30

Insider Trading at UroGen Pharma?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for UroGen Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for UroGen Pharma (NASDAQ:URGN)

68.33% of UroGen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

UroGen Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2021	Millennium Management LLC	74,201	$1.45M	0.0%	+3.7%	0.355%
5/18/2021	Wildcat Capital Management LLC	533,139	$10.39M	1.3%	-57.4%	2.551%
5/18/2021	State of Wisconsin Investment Board	30,427	$0.59M	0.0%	+2.9%	0.146%
5/17/2021	Royal Bank of Canada	103,215	$2.01M	0.0%	+6.5%	0.494%
5/17/2021	Nuveen Asset Management LLC	102,654	$2M	0.0%	-48.1%	0.491%
5/17/2021	Goldman Sachs Group Inc.	103,399	$2.01M	0.0%	-41.0%	0.495%
5/14/2021	Public Employees Retirement System of Ohio	6,900	$0.13M	0.0%	+21.1%	0.033%
5/14/2021	Algert Global LLC	11,630	$0.23M	0.1%	N/A	0.056%
5/14/2021	Alpha Paradigm Partners LLC	31,028	$0.60M	0.2%	N/A	0.148%
5/13/2021	SG Americas Securities LLC	5,235	$0.10M	0.0%	-90.7%	0.025%
5/13/2021	ARK Investment Management LLC	291,870	$5.69M	0.0%	+295.7%	1.397%
5/13/2021	Barclays PLC	20,068	$0.39M	0.0%	+89.7%	0.096%
5/13/2021	Bank of New York Mellon Corp	53,031	$1.03M	0.0%	+2.2%	0.254%
5/13/2021	Citigroup Inc.	1,731	$34K	0.0%	-60.9%	0.008%
5/13/2021	Altshuler Shaham Ltd	42,501	$0.83M	0.0%	+80.8%	0.203%
5/12/2021	Northern Trust Corp	207,296	$4.04M	0.0%	-13.4%	0.992%
5/12/2021	Geode Capital Management LLC	165,165	$3.22M	0.0%	+12.6%	0.790%
5/12/2021	JPMorgan Chase & Co.	98,157	$1.91M	0.0%	+15.5%	0.470%
5/12/2021	Horton Capital Management LLC	619,275	$12.06M	20.7%	+58.6%	2.963%
5/12/2021	UBS Group AG	7,522	$0.15M	0.0%	-36.9%	0.036%
5/11/2021	New York State Common Retirement Fund	18,900	$0.37M	0.0%	-5.0%	0.090%
5/10/2021	Russell Investments Group Ltd.	33,953	$0.66M	0.0%	-40.7%	0.162%
5/10/2021	GSA Capital Partners LLP	23,544	$0.46M	0.1%	N/A	0.113%
5/10/2021	Phoenix Holdings Ltd.	618,718	$12.04M	0.3%	-24.5%	2.961%
5/7/2021	BlackRock Inc.	1,670,605	$32.54M	0.0%	+9.2%	7.994%
5/7/2021	BNP Paribas Arbitrage SA	4,439	$86K	0.0%	+17.4%	0.021%
5/6/2021	Rhumbline Advisers	26,578	$0.52M	0.0%	-7.2%	0.127%
5/6/2021	Meitav Dash Investments Ltd.	63,280	$1.23M	0.0%	N/A	0.303%
5/5/2021	Shikiar Asset Management Inc.	35,350	$0.69M	0.2%	-11.5%	0.169%
5/4/2021	Migdal Insurance & Financial Holdings Ltd.	698,302	$13.60M	0.1%	-5.4%	3.342%
4/28/2021	Bender Robert & Associates	31,131	$0.61M	0.2%	N/A	0.149%
4/26/2021	Bank Hapoalim BM	14,450	$0.28M	0.0%	-51.9%	0.069%
4/23/2021	Parallel Advisors LLC	2,047	$40K	0.0%	+85.6%	0.010%
4/21/2021	Zeke Capital Advisors LLC	517,106	$10.07M	0.7%	N/A	2.475%
2/19/2021	JPMorgan Chase & Co.	84,982	$1.53M	0.0%	-17.2%	0.407%
2/16/2021	Rice Hall James & Associates LLC	102,053	$1.84M	0.1%	N/A	0.488%
2/16/2021	Nuveen Asset Management LLC	197,690	$3.56M	0.0%	-17.7%	0.946%
2/16/2021	Horton Capital Management LLC	390,428	$7.04M	8.1%	+4.0%	1.868%
2/16/2021	ETF Managers Group LLC	32,603	$0.59M	0.0%	+13.7%	0.156%
2/16/2021	Charles Schwab Investment Management Inc.	41,036	$0.74M	0.0%	+2.7%	0.196%
2/12/2021	Public Employees Retirement System of Ohio	5,700	$0.10M	0.0%	N/A	0.027%
2/12/2021	The Manufacturers Life Insurance Company	12,499	$0.23M	0.0%	+4.9%	0.060%
2/12/2021	Credit Suisse AG	1,121,071	$20.20M	0.0%	+0.6%	5.365%
2/11/2021	Trexquant Investment LP	15,812	$0.29M	0.0%	N/A	0.076%
2/11/2021	Northern Trust Corp	239,380	$4.31M	0.0%	-2.7%	1.146%
2/11/2021	Barclays PLC	10,578	$0.19M	0.0%	-19.0%	0.051%
2/11/2021	Citigroup Inc.	4,426	$80K	0.0%	+96.4%	0.021%
2/11/2021	Phoenix Holdings Ltd.	819,682	$14.75M	0.4%	-9.1%	3.922%
2/10/2021	Rhumbline Advisers	28,648	$0.52M	0.0%	+12.3%	0.137%
2/10/2021	Renaissance Technologies LLC	32,800	$0.59M	0.0%	N/A	0.157%
2/9/2021	Annandale Capital LLC	86,254	$1.55M	1.3%	N/A	0.413%
2/9/2021	Wells Fargo & Company MN	34,021	$0.61M	0.0%	+19.9%	0.163%
2/9/2021	Van ECK Associates Corp	4,758	$86K	0.0%	-17.3%	0.023%
2/9/2021	Bank of New York Mellon Corp	51,886	$0.94M	0.0%	-3.5%	0.248%
2/8/2021	Russell Investments Group Ltd.	57,221	$1.03M	0.0%	N/A	0.274%
2/5/2021	BlackRock Inc.	1,529,491	$27.56M	0.0%	+3.0%	7.319%
2/5/2021	Aperio Group LLC	31,421	$0.57M	0.0%	+38.8%	0.150%
2/5/2021	SG Americas Securities LLC	56,244	$1.01M	0.0%	-8.9%	0.269%
2/5/2021	US Bancorp DE	1,910	$35K	0.0%	+52.7%	0.009%
2/4/2021	State of Wisconsin Investment Board	29,569	$0.53M	0.0%	-14.6%	0.141%
2/3/2021	Shikiar Asset Management Inc.	39,950	$0.72M	0.3%	-10.3%	0.191%
2/3/2021	Bank Hapoalim BM	30,020	$0.54M	0.1%	N/A	0.144%
1/25/2021	Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD	21,823	$0.39M	0.1%	N/A	0.104%
11/16/2020	Vivaldi Capital Management LLC	10,000	$0.23M	0.1%	-9.1%	0.048%
11/13/2020	Morgan Stanley	3,683	$71K	0.0%	-96.0%	0.018%
11/13/2020	Charles Schwab Investment Management Inc.	39,970	$0.77M	0.0%	-4.4%	0.191%
11/13/2020	UBS Asset Management Americas Inc.	22,400	$0.43M	0.0%	+17.3%	0.107%
11/12/2020	JPMorgan Chase & Co.	102,658	$1.98M	0.0%	-9.2%	0.491%
11/10/2020	State Street Corp	413,470	$7.98M	0.0%	-2.8%	1.979%
11/10/2020	Phoenix Holdings Ltd.	901,979	$16.41M	0.7%	+0.5%	4.316%
11/9/2020	SG Americas Securities LLC	61,736	$1.19M	0.0%	-53.1%	0.295%
11/6/2020	BlackRock Inc.	1,485,601	$28.66M	0.0%	+1.4%	7.109%
11/6/2020	Aperio Group LLC	22,641	$0.44M	0.0%	+36.6%	0.108%
11/5/2020	California Public Employees Retirement System	40,200	$0.78M	0.0%	+2.6%	0.192%
11/5/2020	Wells Fargo & Company MN	28,368	$0.55M	0.0%	-13.7%	0.136%
10/30/2020	ARK Investment Management LLC	34,212	$0.66M	0.0%	-27.5%	0.164%
10/30/2020	BNP Paribas Arbitrage SA	4,588	$89K	0.0%	+330.0%	0.022%
10/29/2020	DekaBank Deutsche Girozentrale	7,700	$0.15M	0.0%	N/A	0.037%
10/28/2020	Shikiar Asset Management Inc.	44,550	$0.86M	0.3%	-12.9%	0.213%
10/27/2020	Parallel Advisors LLC	2,547	$49K	0.0%	+143.3%	0.012%
8/25/2020	Nuveen Asset Management LLC	337,149	$8.81M	0.0%	+24.5%	1.613%
8/24/2020	FMR LLC	227,503	$5.94M	0.0%	-27.7%	1.089%
8/20/2020	Charles Schwab Investment Management Inc.	41,796	$1.09M	0.0%	+3.0%	0.200%
8/20/2020	Shikiar Asset Management Inc.	51,175	$1.34M	0.6%	-2.6%	0.245%
8/17/2020	California State Teachers Retirement System	47,698	$1.25M	0.0%	+1.4%	0.228%
8/17/2020	Private Advisor Group LLC	3,000	$78K	0.0%	N/A	0.014%
8/14/2020	Bank of America Corp DE	13,665	$0.36M	0.0%	+7.0%	0.065%
8/13/2020	Vivaldi Capital Management LLC	11,000	$0.26M	0.1%	N/A	0.053%
8/13/2020	FMR LLC	227,503	$5.94M	0.0%	-27.7%	1.089%
8/12/2020	Bank of Montreal Can	1,758	$42K	0.0%	+459.9%	0.008%
8/12/2020	American International Group Inc.	11,853	$0.31M	0.0%	+6.9%	0.057%
8/12/2020	Algert Global LLC	10,880	$0.28M	0.1%	N/A	0.052%
8/12/2020	Goldman Sachs Group Inc.	143,265	$3.74M	0.0%	+19.8%	0.686%
8/12/2020	Horton Capital Management LLC	383,428	$10.02M	7.5%	+52.4%	1.835%
8/12/2020	Bank of New York Mellon Corp	55,313	$1.44M	0.0%	+14.8%	0.265%
8/12/2020	State of Wisconsin Investment Board	32,324	$0.84M	0.0%	+6.2%	0.155%
8/12/2020	California Public Employees Retirement System	39,200	$1.02M	0.0%	-6.4%	0.188%
8/11/2020	Macquarie Group Ltd.	1,122	$29K	0.0%	N/A	0.005%
8/11/2020	Aigen Investment Management LP	10,750	$0.28M	0.0%	+26.4%	0.051%
8/10/2020	Phoenix Holdings Ltd.	897,464	$22.25M	0.9%	+1.6%	4.294%

Data available starting January 2016

UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-302 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. It also has a strategic research agreement with the Johns Hopkins University to explore the potential of checkpoint inhibitors combined with RTGel in glioblastoma multiform. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

Today's Range

Now: $15.57

$15.29

$15.57

50 Day Range

MA: $16.63

$14.87

$18.56

52 Week Range

Now: $15.57

$14.61

$28.20

Volume

907 shs

Average Volume

172,140 shs

Market Capitalization

$325.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of UroGen Pharma?

UroGen Pharma's top insider investors include:

Elizabeth A Barrett (CEO)
Mark Schoenberg (Insider)
Peter P Pfreundschuh (CFO)
Stephen Mullennix (COO)
Molly Henderson (CFO)

5 Signs That Inflation Is About To Wreck America

From The Gold Letter | Ad

A weak dollar. 2. Limited supply of critical resources. 3. Prices are skyrocketing. 4. Demand is rising. (Sending prices even higher) 5. Treasury yields tripled over the last year!

How To Protect Your Wealth From This Inflation